High dose stereotactic body radiotherapy using three fractions for colorectal oligometastases
Authors:
- 1 February 2012
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 106 (2) , 138-143
Abstract
Background and Objectives: This study evaluated the treatment result of high dose stereotactic body radiation therapy (SBRT) for colorectal oligometastases.Methods: Between 2003 and 2009, 41 patients with 50 lesions confined to one organ from colorectal cancer (CRC) and treated with high dose SBRT ≥45 Gy were retrospectively reviewed. Lymph nodes (LNs) (18 patients) were the most frequent sites followed in order by lung (12) and liver (11). SBRT doses ranged from 45 to 60 Gy in three fractions (median 48 Gy). The cumulative gross tumor volume (GTV) ranged from 2 to 123 ml (median 13 ml).Results: The median follow‐up period from the SBRT date was 28 months (range, 6–65 months). The 3‐year local control and overall survival rates were 64 and 60%, and the respective 5‐year rates were 57 and 38%. Cumulative GTV and SBRT dose were statistically significant prognostic factors for local control. The grade 3 or 4 complications occurred in three patients (7%).Conclusions: High dose SBRT for colorectal oligometastases was found to produce results comparable with surgical series. To improve local control, dose higher than 48 Gy are recommend when possible, but further study will be required to define the optimal normal tissue constraints and acceptable toxicity. J. Surg. Oncol. 2012; 106:138–143.Keywords
This publication has 24 references indexed in Scilit:
- Oligometastases revisitedNature Reviews Clinical Oncology, 2011
- Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastasesCancer, 2010
- Oligometastases confined one organ from colorectal cancer treated by SBRTClinical & Experimental Metastasis, 2010
- Oligometastases and Oligo-recurrence: The New Era of Cancer TherapyJapanese Journal of Clinical Oncology, 2010
- Local Control of Metastatic Lung Tumors Treated with SBRT of 48 Gy in Four Fractions: In Comparison with Primary Lung CancerJapanese Journal of Clinical Oncology, 2009
- Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung MetastasesJournal of Clinical Oncology, 2009
- Stereotactic Body Radiation Therapy Using Three Fractions for Isolated Lung Recurrence from Colorectal CancerOncology, 2009
- The Role and Limitations of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography (FDG-PET) Scan and Computerized Tomography (CT) in Restaging Patients with Hepatic Colorectal Metastases Following Neoadjuvant Chemotherapy: Comparison with Operative and Pathological FindingsJournal of Gastrointestinal Surgery, 2007
- Phase II study on stereotactic body radiotherapy of colorectal metastasesActa Oncologica, 2006
- Surgical resection of locally recurrent colorectal adenocarcinomaBritish Journal of Surgery, 1998